Bioxytran (BIXT) EBT Margin Growth (3y) (2013 - 2018)
Bioxytran (BIXT) EBT Margin Growth (3y) (2013 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 6,685.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2,054.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8,006.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 9,980.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -9,922.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 31,363.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -5,319.00 |
| 10 | Bioxytran | 2.52 Mn | 2.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 322,424.00 |
| Mar 31, 2018 | 5,747.00 |
| Dec 31, 2017 | -221,568.00 |
| Sep 30, 2017 | 273,532.00 |
| Jun 30, 2017 | -50,608.00 |
| Mar 31, 2017 | -89,869.00 |
| Dec 31, 2016 | 29,588.00 |
| Sep 30, 2016 | 28,612.00 |
| Jun 30, 2016 | 38,488.00 |
| Mar 31, 2016 | -59,123.00 |
| Dec 31, 2015 | 114,103.00 |
| Sep 30, 2015 | 509,578.00 |
| Jun 30, 2015 | -266,485.00 |
| Mar 31, 2015 | 29,569.00 |
| Dec 31, 2014 | 1.30 Mn |
| Sep 30, 2014 | -6,820.00 |
| Jun 30, 2014 | 26,040.00 |
| Mar 31, 2014 | 1.76 Mn |
| Dec 31, 2013 | 108,510.00 |
| Sep 30, 2013 | 349,040.00 |